Â鶹Çø

Too much of a good thing

Medications for opioid use disorder (MOUD), and overdose education and naloxone distribution (OEND), are among the most supported evidence-based practices (EBPs) in addiction medicine. Yet the real-world deployment of those EBPs at scale in diverse communities remains limited. Research shows that stigma toward these EBPs, toward people who use drugs or people receiving MOUD, plays a significant role in limiting the deployment and use of these EBPs in communities impacted by the opioid crisis.

Too much of a good thing

Communication might just be the most valuable tool we have.

Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience.

Medicaid Alignment with State SUD Requirements

New Standards for Adolescent Substance Use Disorder Care

If we hope to improve our response to the addiction and overdose crisis, we must focus on when addiction commonly starts: adolescence. Addiction is a pediatric-onset illness, as ongoing neurodevelopment makes the adolescent brain particularly vulnerable to the effects of substances. In fact, 80% of adults with substance use disorder (SUD) begin using substances before the age of 18.1,2 Not only is the neurobiology of adolescents unique, but so are their social, educational, and mental and physical health needs.

A opioid receptor superagonist analgesic with minimal adverse effects

New ASAM Implementation Guide for Hospital and EDs